ID   GNAI2_RAT               Reviewed;         355 AA.
AC   P04897;
DT   13-AUG-1987, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   02-OCT-2024, entry version 199.
DE   RecName: Full=Guanine nucleotide-binding protein G(i) subunit alpha-2;
DE   AltName: Full=Adenylate cyclase-inhibiting G alpha protein;
GN   Name=Gnai2; Synonyms=Gnai-2;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=3086867; DOI=10.1073/pnas.83.11.3776;
RA   Itoh H., Kozasa T., Nagata S., Nakamura S., Katada T., Ui M., Iwai S.,
RA   Ohtsuka E., Kawasaki H., Suzuki K., Kaziro Y.;
RT   "Molecular cloning and sequence determination of cDNAs for alpha subunits
RT   of the guanine nucleotide-binding proteins Gs, Gi, and Go from rat brain.";
RL   Proc. Natl. Acad. Sci. U.S.A. 83:3776-3780(1986).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=2820999; DOI=10.1016/s0021-9258(18)47929-x;
RA   Jones D.T., Reed R.R.;
RT   "Molecular cloning of five GTP-binding protein cDNA species from rat
RT   olfactory neuroepithelium.";
RL   J. Biol. Chem. 262:14241-14249(1987).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   PROTEIN SEQUENCE OF 12-126.
RX   PubMed=2159473; DOI=10.1016/s0021-9258(19)39064-7;
RA   Linder M.E., Ewald D.A., Miller R.J., Gilman A.G.;
RT   "Purification and characterization of Go alpha and three types of Gi alpha
RT   after expression in Escherichia coli.";
RL   J. Biol. Chem. 265:8243-8251(1990).
RN   [5]
RP   INTERACTION WITH GPSM1.
RX   PubMed=11121039; DOI=10.1073/pnas.97.26.14364;
RA   de Vries L., Fischer T., Tronchere H., Brothers G.M., Strockbine B.,
RA   Siderovski D.P., Farquhar M.G.;
RT   "Activator of G protein signaling 3 is a guanine dissociation inhibitor for
RT   Galpha i subunits.";
RL   Proc. Natl. Acad. Sci. U.S.A. 97:14364-14369(2000).
RN   [6]
RP   INTERACTION WITH RGS12 AND RGS14.
RX   PubMed=11387333; DOI=10.1074/jbc.m103208200;
RA   Kimple R.J., De Vries L., Tronchere H., Behe C.I., Morris R.A.,
RA   Gist Farquhar M., Siderovski D.P.;
RT   "RGS12 and RGS14 GoLoco motifs are G alpha(i) interaction sites with
RT   guanine nucleotide dissociation inhibitor activity.";
RL   J. Biol. Chem. 276:29275-29281(2001).
RN   [7]
RP   SUBCELLULAR LOCATION.
RX   PubMed=16870394; DOI=10.1016/j.cellsig.2006.06.002;
RA   Shu F.J., Ramineni S., Amyot W., Hepler J.R.;
RT   "Selective interactions between Gi alpha1 and Gi alpha3 and the GoLoco/GPR
RT   domain of RGS14 influence its dynamic subcellular localization.";
RL   Cell. Signal. 19:163-176(2007).
RN   [8]
RP   MUTAGENESIS OF MET-82; VAL-85; LYS-86; ASN-90; GLN-92; ALA-96; PRO-98;
RP   GLN-99; SER-111; CYS-112; PRO-121 AND GLU-122.
RX   PubMed=15337739; DOI=10.1074/jbc.m407409200;
RA   Mittal V., Linder M.E.;
RT   "The RGS14 GoLoco domain discriminates among Galphai isoforms.";
RL   J. Biol. Chem. 279:46772-46778(2004).
RN   [9]
RP   SUBCELLULAR LOCATION.
RX   PubMed=17635935; DOI=10.1083/jcb.200604114;
RA   Cho H., Kehrl J.H.;
RT   "Localization of Gi alpha proteins in the centrosomes and at the midbody:
RT   implication for their role in cell division.";
RL   J. Cell Biol. 178:245-255(2007).
RN   [10]
RP   INTERACTION WITH CCDC88A.
RX   PubMed=19211784; DOI=10.1073/pnas.0900294106;
RA   Garcia-Marcos M., Ghosh P., Farquhar M.G.;
RT   "GIV is a nonreceptor GEF for G alpha i with a unique motif that regulates
RT   Akt signaling.";
RL   Proc. Natl. Acad. Sci. U.S.A. 106:3178-3183(2009).
RN   [11]
RP   INTERACTION WITH NUCB1.
RX   PubMed=21653697; DOI=10.1074/jbc.m110.204099;
RA   Garcia-Marcos M., Kietrsunthorn P.S., Wang H., Ghosh P., Farquhar M.G.;
RT   "G Protein binding sites on Calnuc (nucleobindin 1) and NUCB2 (nucleobindin
RT   2) define a new class of G(alpha)i-regulatory motifs.";
RL   J. Biol. Chem. 286:28138-28149(2011).
CC   -!- FUNCTION: Guanine nucleotide-binding proteins (G proteins) are involved
CC       as modulators or transducers in various transmembrane signaling
CC       systems. The G(i) proteins are involved in hormonal regulation of
CC       adenylate cyclase: they inhibit the cyclase in response to beta-
CC       adrenergic stimuli. May play a role in cell division.
CC   -!- SUBUNIT: G proteins are composed of 3 units; alpha, beta and gamma. The
CC       alpha chain contains the guanine nucleotide binding site. In this
CC       context, interacts with GNB2 (By similarity). Interacts with UNC5B (By
CC       similarity). Interacts with GPSM1 (PubMed:11121039). Interacts with
CC       RGS12 and RGS14 (PubMed:11387333). Interacts (inactive GDP-bound form)
CC       with NUCB1 (via GBA motif); the interaction leads to activation of
CC       GNAI3 (PubMed:21653697). Interacts (inactive GDP-bound form) with
CC       CCDC88C/DAPLE (via GBA motif) (By similarity). Interacts (inactive GDP-
CC       bound form) with CCDC8A/GIV (via GBA motif) (PubMed:19211784).
CC       {ECO:0000250|UniProtKB:P04899, ECO:0000269|PubMed:11121039,
CC       ECO:0000269|PubMed:11387333, ECO:0000269|PubMed:19211784,
CC       ECO:0000269|PubMed:21653697}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Cell membrane.
CC       Cytoplasm, cytoskeleton, microtubule organizing center, centrosome.
CC       Membrane {ECO:0000250|UniProtKB:P04899}; Lipid-anchor
CC       {ECO:0000250|UniProtKB:P04899}. Note=Localizes in the centrosomes of
CC       interphase and mitotic cells. Detected at the cleavage furrow and/or
CC       the midbody (By similarity). {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M12672; AAA41260.1; -; mRNA.
DR   EMBL; M17528; AAA40824.1; -; mRNA.
DR   EMBL; BC078806; AAH78806.1; -; mRNA.
DR   PIR; D27423; RGRTI2.
DR   RefSeq; NP_112297.1; NM_031035.3.
DR   RefSeq; XP_006243920.1; XM_006243858.1.
DR   AlphaFoldDB; P04897; -.
DR   SMR; P04897; -.
DR   BioGRID; 249564; 4.
DR   CORUM; P04897; -.
DR   DIP; DIP-607N; -.
DR   IntAct; P04897; 3.
DR   MINT; P04897; -.
DR   STRING; 10116.ENSRNOP00000022550; -.
DR   ChEMBL; CHEMBL4524034; -.
DR   iPTMnet; P04897; -.
DR   PhosphoSitePlus; P04897; -.
DR   SwissPalm; P04897; -.
DR   jPOST; P04897; -.
DR   PaxDb; 10116-ENSRNOP00000022550; -.
DR   Ensembl; ENSRNOT00000022550.7; ENSRNOP00000022550.4; ENSRNOG00000016592.7.
DR   Ensembl; ENSRNOT00055022918; ENSRNOP00055018581; ENSRNOG00055013363.
DR   Ensembl; ENSRNOT00060050877; ENSRNOP00060042319; ENSRNOG00060029241.
DR   Ensembl; ENSRNOT00065013208; ENSRNOP00065009777; ENSRNOG00065008318.
DR   GeneID; 81664; -.
DR   KEGG; rno:81664; -.
DR   UCSC; RGD:620243; rat.
DR   AGR; RGD:620243; -.
DR   CTD; 2771; -.
DR   RGD; 620243; Gnai2.
DR   eggNOG; KOG0082; Eukaryota.
DR   GeneTree; ENSGT00940000155125; -.
DR   HOGENOM; CLU_014184_6_0_1; -.
DR   InParanoid; P04897; -.
DR   OMA; GMGCTVS; -.
DR   OrthoDB; 2897309at2759; -.
DR   PhylomeDB; P04897; -.
DR   TreeFam; TF300673; -.
DR   Reactome; R-RNO-170670; Adenylate cyclase inhibitory pathway.
DR   Reactome; R-RNO-392170; ADP signalling through P2Y purinoceptor 12.
DR   Reactome; R-RNO-400042; Adrenaline,noradrenaline inhibits insulin secretion.
DR   Reactome; R-RNO-418594; G alpha (i) signalling events.
DR   Reactome; R-RNO-9009391; Extra-nuclear estrogen signaling.
DR   SABIO-RK; P04897; -.
DR   PRO; PR:P04897; -.
DR   Proteomes; UP000002494; Chromosome 8.
DR   Bgee; ENSRNOG00000016592; Expressed in spleen and 19 other cell types or tissues.
DR   ExpressionAtlas; P04897; baseline and differential.
DR   GO; GO:0044297; C:cell body; ISO:RGD.
DR   GO; GO:0005813; C:centrosome; ISS:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IEA:Ensembl.
DR   GO; GO:0030425; C:dendrite; ISO:RGD.
DR   GO; GO:0005834; C:heterotrimeric G-protein complex; IBA:GO_Central.
DR   GO; GO:0098686; C:hippocampal mossy fiber to CA3 synapse; ISO:RGD.
DR   GO; GO:0030496; C:midbody; ISS:UniProtKB.
DR   GO; GO:0098992; C:neuronal dense core vesicle; ISO:RGD.
DR   GO; GO:0005654; C:nucleoplasm; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0001664; F:G protein-coupled receptor binding; IBA:GO_Central.
DR   GO; GO:0031683; F:G-protein beta/gamma-subunit complex binding; IBA:GO_Central.
DR   GO; GO:0005525; F:GTP binding; IEA:UniProtKB-KW.
DR   GO; GO:0003924; F:GTPase activity; IBA:GO_Central.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0007189; P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; IMP:RGD.
DR   GO; GO:0007193; P:adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway; ISO:RGD.
DR   GO; GO:0051301; P:cell division; ISS:UniProtKB.
DR   GO; GO:0008283; P:cell population proliferation; ISO:RGD.
DR   GO; GO:0007213; P:G protein-coupled acetylcholine receptor signaling pathway; ISO:RGD.
DR   GO; GO:0001973; P:G protein-coupled adenosine receptor signaling pathway; IDA:RGD.
DR   GO; GO:0007186; P:G protein-coupled receptor signaling pathway; IDA:RGD.
DR   GO; GO:0007214; P:gamma-aminobutyric acid signaling pathway; IDA:RGD.
DR   GO; GO:0050804; P:modulation of chemical synaptic transmission; ISO:RGD.
DR   GO; GO:0071878; P:negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway; IDA:RGD.
DR   GO; GO:2001234; P:negative regulation of apoptotic signaling pathway; IMP:RGD.
DR   GO; GO:0045955; P:negative regulation of calcium ion-dependent exocytosis; IMP:RGD.
DR   GO; GO:0050805; P:negative regulation of synaptic transmission; IDA:RGD.
DR   GO; GO:0030335; P:positive regulation of cell migration; IMP:RGD.
DR   GO; GO:0008284; P:positive regulation of cell population proliferation; IMP:RGD.
DR   GO; GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IMP:RGD.
DR   GO; GO:0046628; P:positive regulation of insulin receptor signaling pathway; IMP:RGD.
DR   GO; GO:2000179; P:positive regulation of neural precursor cell proliferation; IMP:RGD.
DR   GO; GO:0032930; P:positive regulation of superoxide anion generation; IMP:RGD.
DR   GO; GO:0035810; P:positive regulation of urine volume; IMP:RGD.
DR   GO; GO:1904707; P:positive regulation of vascular associated smooth muscle cell proliferation; IMP:RGD.
DR   GO; GO:0051924; P:regulation of calcium ion transport; IDA:RGD.
DR   CDD; cd00066; G-alpha; 1.
DR   Gene3D; 1.10.400.10; GI Alpha 1, domain 2-like; 1.
DR   Gene3D; 3.40.50.300; P-loop containing nucleotide triphosphate hydrolases; 1.
DR   InterPro; IPR001408; Gprotein_alpha_I.
DR   InterPro; IPR001019; Gprotein_alpha_su.
DR   InterPro; IPR011025; GproteinA_insert.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   PANTHER; PTHR10218; GTP-BINDING PROTEIN ALPHA SUBUNIT; 1.
DR   PANTHER; PTHR10218:SF73; GUANINE NUCLEOTIDE-BINDING PROTEIN G(I) SUBUNIT ALPHA-2; 1.
DR   Pfam; PF00503; G-alpha; 1.
DR   PRINTS; PR00318; GPROTEINA.
DR   PRINTS; PR00441; GPROTEINAI.
DR   SMART; SM00275; G_alpha; 1.
DR   SUPFAM; SSF52540; P-loop containing nucleoside triphosphate hydrolases; 1.
DR   SUPFAM; SSF47895; Transducin (alpha subunit), insertion domain; 1.
DR   PROSITE; PS51882; G_ALPHA; 1.
PE   1: Evidence at protein level;
KW   Cell cycle; Cell division; Cell membrane; Cytoplasm; Cytoskeleton;
KW   Direct protein sequencing; GTP-binding; Lipoprotein; Magnesium; Membrane;
KW   Metal-binding; Myristate; Nucleotide-binding; Palmitate;
KW   Reference proteome; Transducer.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000250|UniProtKB:P04899"
FT   CHAIN           2..355
FT                   /note="Guanine nucleotide-binding protein G(i) subunit
FT                   alpha-2"
FT                   /id="PRO_0000203682"
FT   DOMAIN          32..355
FT                   /note="G-alpha"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01230"
FT   REGION          35..48
FT                   /note="G1 motif"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01230"
FT   REGION          174..182
FT                   /note="G2 motif"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01230"
FT   REGION          197..206
FT                   /note="G3 motif"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01230"
FT   REGION          266..273
FT                   /note="G4 motif"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01230"
FT   REGION          325..330
FT                   /note="G5 motif"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01230"
FT   BINDING         40..47
FT                   /ligand="GTP"
FT                   /ligand_id="ChEBI:CHEBI:37565"
FT                   /evidence="ECO:0000250"
FT   BINDING         47
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /evidence="ECO:0000250"
FT   BINDING         176..182
FT                   /ligand="GTP"
FT                   /ligand_id="ChEBI:CHEBI:37565"
FT                   /evidence="ECO:0000250"
FT   BINDING         182
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /evidence="ECO:0000250"
FT   BINDING         201..205
FT                   /ligand="GTP"
FT                   /ligand_id="ChEBI:CHEBI:37565"
FT                   /evidence="ECO:0000250"
FT   BINDING         270..273
FT                   /ligand="GTP"
FT                   /ligand_id="ChEBI:CHEBI:37565"
FT                   /evidence="ECO:0000250"
FT   BINDING         327
FT                   /ligand="GTP"
FT                   /ligand_id="ChEBI:CHEBI:37565"
FT                   /evidence="ECO:0000250"
FT   LIPID           2
FT                   /note="N-myristoyl glycine"
FT                   /evidence="ECO:0000250|UniProtKB:P04899"
FT   LIPID           3
FT                   /note="S-palmitoyl cysteine"
FT                   /evidence="ECO:0000250"
FT   VARIANT         166..167
FT                   /note="SD -> PN (in tryptic peptides)"
FT   MUTAGEN         82
FT                   /note="M->I: Increases sensitivity to RGS14 GTPase
FT                   activity; when associated with I-85; R-86; R-90; K-92; G-
FT                   96; A-98; A-99; A-111; G-112; T-121 and A-122. Does not
FT                   increase sensitivity to RGS14 GTPase activity; when
FT                   associated with I-85 and A-111."
FT                   /evidence="ECO:0000269|PubMed:15337739"
FT   MUTAGEN         85
FT                   /note="V->I: Increases sensitivity to RGS14 GTPase
FT                   activity; when associated with I-82; R-86; R-90; K-92; G-
FT                   96; A-98; A-99; A-111; G-112; T-121 and A-122. Does not
FT                   increase sensitivity to RGS14 GTPase activity; when
FT                   associated with I-82 and A-111."
FT                   /evidence="ECO:0000269|PubMed:15337739"
FT   MUTAGEN         86
FT                   /note="K->R: Increases sensitivity to RGS14 GTPase
FT                   activity; when associated with I-82; I-85; R-90; K-92; G-
FT                   96; A-98; A-99; A-111; G-112; T-121 and A-122."
FT                   /evidence="ECO:0000269|PubMed:15337739"
FT   MUTAGEN         90
FT                   /note="N->R: Increases sensitivity to RGS14 GTPase
FT                   activity; when associated with I-82; I-85; R-86; K-92; G-
FT                   96; A-98; A-99; A-111; G-112; T-121 and A-122."
FT                   /evidence="ECO:0000269|PubMed:15337739"
FT   MUTAGEN         92
FT                   /note="Q->K: Increases sensitivity to RGS14 GTPase
FT                   activity; when associated with I-82; I-85; R-86; R-90; G-
FT                   96; A-98; A-99; A-111; G-112; T-121 and A-122."
FT                   /evidence="ECO:0000269|PubMed:15337739"
FT   MUTAGEN         96
FT                   /note="A->G: Increases sensitivity to RGS14 GTPase
FT                   activity; when associated with I-82; I-85; R-86; R-90; K-
FT                   92; A-98; A-99; A-111; G-112; T-121 and A-122."
FT                   /evidence="ECO:0000269|PubMed:15337739"
FT   MUTAGEN         98
FT                   /note="P->A: Increases sensitivity to RGS14 GTPase
FT                   activity; when associated with I-82; I-85; R-86; R-90; K-
FT                   92; G-96; A-99; A-111; G-112; T-121 and A-122."
FT                   /evidence="ECO:0000269|PubMed:15337739"
FT   MUTAGEN         99
FT                   /note="Q->A: Increases sensitivity to RGS14 GTPase
FT                   activity; when associated with I-82; I-85; R-86; R-90; K-
FT                   92; G-96; A-98; A-111; G-112; T-121 and A-122."
FT                   /evidence="ECO:0000269|PubMed:15337739"
FT   MUTAGEN         111
FT                   /note="S->A: Increases sensitivity to RGS14 GTPase
FT                   activity; when associated with I-82; I-85; R-86; R-90; K-
FT                   92; G-96; A-98; A-99; G-112; T-121 and A-122. Does not
FT                   increase sensitivity to RGS14 GTPase activity; when
FT                   associated with G-112; T-121 and A-122. Does not increase
FT                   sensitivity to RGS14 GTPase activity; when associated with
FT                   I-82 and A-85."
FT                   /evidence="ECO:0000269|PubMed:15337739"
FT   MUTAGEN         112
FT                   /note="C->G: Increases sensitivity to RGS14 GTPase
FT                   activity; when associated with I-82; I-85; R-86; R-90; K-
FT                   92; G-96; A-98; A-99; A-111; T-121 and A-122. Does not
FT                   increase sensitivity to RGS14 GTPase activity; when
FT                   associated with G-111; T-121 and A-122."
FT                   /evidence="ECO:0000269|PubMed:15337739"
FT   MUTAGEN         117
FT                   /note="Missing: Increases sensitivity to RGS14 GTPase
FT                   activity; when associated with I-82; I-85; R-86; R-90; K-
FT                   92; G-96; A-98; A-99; A-111; G-112; T-121 and A-122. Does
FT                   not increase sensitivity to RGS14 GTPase activity; when
FT                   associated with G-111; G-112; T-121 and A-122."
FT   MUTAGEN         121
FT                   /note="P->T: Increases sensitivity to RGS14 GTPase
FT                   activity; when associated with I-82; I-85; R-86; R-90; K-
FT                   92; G-96; A-98; A-99; A-111; G-112 and A-122. Does not
FT                   increase sensitivity to RGS14 GTPase activity; when
FT                   associated with G-111; G-112 and A-122."
FT                   /evidence="ECO:0000269|PubMed:15337739"
FT   MUTAGEN         122
FT                   /note="E->A: Increases sensitivity to RGS14 GTPase
FT                   activity; when associated with I-82; I-85; R-86; R-90; K-
FT                   92; G-96; A-98; A-99; A-111; G-112 and T-121. Does not
FT                   increase sensitivity to RGS14 GTPase activity; when
FT                   associated with G-111; G-112 and T-121."
FT                   /evidence="ECO:0000269|PubMed:15337739"
SQ   SEQUENCE   355 AA;  40499 MW;  9360ABAC6BDC493E CRC64;
     MGCTVSAEDK AAAERSKMID KNLREDGEKA AREVKLLLLG AGESGKSTIV KQMKIIHEDG
     YSEEECRQYR AVVYSNTIQS IMAIVKAMGN LQIDFADPQR ADDARQLFAL SCAAEEQGML
     PEDLSGVIRR LWADHGVQAC FGRSREYQLN DSAAYYLNDL ERIAQSDYIP TQQDVLRTRV
     KTTGIVETHF TFKDLHFKMF DVGGQRSERK KWIHCFEGVT AIIFCVALSA YDLVLAEDEE
     MNRMHESMKL FDSICNNKWF TDTSIILFLN KKDLFEEKIT QSPLTICFPE YTGANKYDEA
     ASYIQSKFED LNKRKDTKEI YTHFTCATDT KNVQFVFDAV TDVIIKNNLK DCGLF
//
